If left untreated, obesity can lead to a range of serious health conditions, including Type 2 diabetes, high blood pressure and cholesterol, heart disease, sleep apnea, osteoarthritis, and cancer
Real-world analysis of glucagon like peptide-1 (GLP-1) agonist obesity treatment year-two clinical and cost outcomes
The drug also reduces blood pressure in those patients who have high readings
Well, it also sounds like, Tyna, that the consumer, the patient really needs, and I think this is with everything, and you know, now weve got the internet, good or bad, where you can start to do your research, find your trusted sources
Our providers can help determine whether your symptoms are related to injection technique, skin preparation, medication additives, preservatives, or another cause and recommend appropriate next steps
In studies, semaglutide was more effective at reducing body weight and HbA1c than placebo